Plasma apelin levels in obstructive sleep apnea and the effect of continuous positive airway pressure therapy

Journal of Endocrinology

Volumn 203, Issue 1, 2009, Pages 181-188

  Henley, David E ^a,b,d   Buchanan, Fiona ^c   Gibson, Rosemary ^c   Douthwaite, Jennie A ^a   Wood, Susan A ^a   Woltersdorf, Wolfram W ^c   Catterall, James R ^c   Lightman, Stafford L ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APELIN; GLUCOSE; HYDROCORTISONE; INSULIN; APLN PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; MALE; ORAL GLUCOSE TOLERANCE TEST; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME; TREATMENT RESPONSE; AGED; BLOOD; CIRCADIAN RHYTHM; GLUCOSE TOLERANCE TEST; MIDDLE AGED; OBESITY;

ADULT; AGED; CIRCADIAN RHYTHM; CONTINUOUS POSITIVE AIRWAY PRESSURE; GLUCOSE TOLERANCE TEST; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; OBESITY; SLEEP APNEA, OBSTRUCTIVE;

EID: 70349770126     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-09-0245     Document Type: Article

References (54)

1. Andersen CU, Markvardsen LH, Hilberg O & Simonsen U 2009 Pulmonary apelin levels and effects in rats with hypoxic pulmonary hypertension. Respiratory Medicine DOI:10.1016/j.rmed.2009.05.011.
2. Arias MA, Garcia-Rio F, Alonso-Fernandez A, Hernanz A, Hidalgo R, Martinez-Mateo V, Bartolome S & Rodriguez-Padial L 2008 CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea. European Respiratory Journal 32 1009-1015.
3. Atkeson A & Jelic S 2008 Mechanisms of endothelial dysfunction in obstructive sleep apnea. Vascular Health and Risk Management 4 1327-1335.
4. Boucher J, Masri B, Daviaud D, Gesta S, Guigne C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B, Carpene C et al. 2005 Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 146 1764-1771. (Pubitemid 40396885)
5. Bradley TD & Floras JS 2009 Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373 82-93.
6. Buckley TM & Schatzberg AF 2005 On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. Journal of Clinical Endocrinology and Metabolism 90 3106-3114.
7. Carpene C, Dray C, Attane C, Valet P, Portillo MP, Churruca I, Milagro FI & Castan-Laurell I 2007 Expanding role for the apelin/APJ system in physiopathology. Journal of Physiology and Biochemistry 63 359-374.
8. Chandrasekaran B, Dar O & McDonagh T 2008 The role of apelin in cardiovascular function and heart failure. European Journal of Heart Failure 10 725-732.
9. Chong KS, Gardner RS, Morton JJ, Ashley EA & McDonagh TA 2006 Plasma concentrations of the novel peptide apelin are decreased in patients with chronic heart failure. European Journal of Heart Failure 8 355-360.
10. Ciftci TU, Kokturk O, Bukan N & Bilgihan A 2004 The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. Cytokine 28 87-91. (Pubitemid 39302489)
11. Collop N 2007 The effect of obstructive sleep apnea on chronic medical disorders. Cleveland Clinic Journal of Medicine 74 72-78. (Pubitemid 46117631)
12. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM & Wilding JP 2004 Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. European Heart Journal 25 735-741. (Pubitemid 38647933)
13. Daviaud D, Boucher J, Gesta S, Dray C, Guigne C, Quilliot D, Ayav A, Ziegler O, Carpene C, Saulnier-Blache JS et al. 2006 TNFalpha up-regulates apelin expression in human and mouse adipose tissue. FASEB Journal 20 1528-1530.
14. Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M & Tkacova R 2008 Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome. Chest 134 686-692.
15. Dray C, Knauf C, Daviaud D, Waget A, Boucher J, Buleon M, Cani PD, Attane C, Guigne C, Carpene C et al. 2008 Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metabolism 8 437-445.
16. Erdem G, Dogru T, Tasci I, Sonmez A & Tapan S 2008 Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus. Experimental and Clinical Endocrinology and Diabetes 116 289-292. (Pubitemid 351798738)
17. Ernst KV, Ashley EA, Charo D, Kawana M, Fajardo D & Bermstein D 2006 Apelin regulates cardiac contractility and rescues neurohormonal heart failure. Journal of Cardiac Failure 12 S1.
18. Foldes G, Horkay F, Szokodi I, Vuolteenaho O, Ilves M, Lindstedt KA, Mayranpaa M, Sarman B, Seres L, Skoumal R et al. 2003 Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochemical and Biophysical Research Communications 308 480-485. (Pubitemid 36945517)
19. Gilon P & Henquin JC 2001 Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function. Endocrine Reviews 22 565-604. (Pubitemid 32958576)
20. Glassford AJ, Yue P, Sheikh AY, Chun HJ, Zarafshar S, Chan DA, Reaven GM, Quertermous T & Tsao PS 2007 HIF-1 regulates hypoxia- and insulin-induced expression of apelin in adipocytes. American Journal of Physiology. Endocrinology and Metabolism 293 E1590-E1596. (Pubitemid 350255108)
21. Goetze JP, Rehfeld JF, Carlsen J, Videbaek R, Andersen CB, Boesgaard S & Friis-Hansen L 2006 Apelin: a new plasma marker of cardiopulmonary disease. Regulatory Peptides 133 134-138. (Pubitemid 41820346)
22. Harsch IA, Schahin SP, Radespiel-Troger M, Weintz O, Jahreiss H, Fuchs FS, Wiest GH, Hahn EG, Lohmann T, Konturek PC et al. 2004 Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. American Journal of Respiratory and Critical Care Medicine 169 156-162. (Pubitemid 38114528)
23. Hashimoto T, Kihara M, Imai N, Yoshida S, Shimoyamada H, Yasuzaki H, Ishida J, Toya Y, Kiuchi Y, Hirawa N et al. 2007 Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclerosis. American Journal of Pathology 171 1705-1712. (Pubitemid 350158330)
24. Heinonen MV, Purhonen AK, Miettinen P, Paakkonen M, Pirinen E, Alhava E, Akerman K & Herzig KH 2005 Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding. Regulatory Peptides 130 7-13. (Pubitemid 40966016)
25. Henley DE, Leendertz JA, Russell GM, Wood SA, Taheri S, Woltersdorf WW & Lightman SL 2009 Development of an automated blood sampling system for use in humans. Journal of Medical Engineering and Technology 33 199-208.
26. Hosoya M, Kawamata Y, Fukusumi S, Fujii R, Habata Y, Hinuma S, Kitada C, Honda S, Kurokawa T, Onda H et al. 2000 Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. Journal of Biological Chemistry 275 21061-21067. (Pubitemid 30481796)
27. Jelic S, Padeletti M, Kawut SM, Higgins C, Canfield SM, Onat D, Colombo PC, Basner RC, Factor P & LeJemtel TH 2008 Inflammation, oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 117 2270-2278.
28. Kawamata Y, Habata Y, Fukusumi S, Hosoya M, Fujii R, Hinuma S, Nishizawa N, Kitada C, Onda H, Nishimura O et al. 2001 Molecular properties of apelin: tissue distribution and receptor binding. Biochimica et Biophysica Acta 1538 162-171. (Pubitemid 32402239)
29. Kleinz MJ & Davenport AP 2004 Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells. Regulatory Peptides 118 119-125. (Pubitemid 38296725)
30. Kleinz MJ & Davenport AP 2005 Emerging roles of apelin in biology and medicine. Pharmacology & Therapeutics 107 198-211.
31. Lee DK, Saldivia VR, Nguyen T, Cheng R, George SR & O'dowd BF 2005 Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. Endocrinology 146 231-236.
32. Li L, Yang G, Li Q, Tang Y, Yang M, Yang H & Li K 2006 Changes and relations of circulating visfatin, apelin, and resistin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Experimental and Clinical Endocrinology and Diabetes 114 544-548. (Pubitemid 46087259)
33. Narkiewicz K & Somers VK 2003 Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiologica Scandinavica 177 385-390. (Pubitemid 36337642)
34. Newson MJ, Roberts EM, Pope GR, Lolait SJ & O'Carroll AM 2009 The effects of apelin on hypothalamic-pituitary-adrenal axis neuroendocrine function are mediated through corticotrophin-releasing factor- and vasopressin-dependent mechanisms. Journal of Endocrinology 202 123-129.
35. O'Carroll AM, Don AL & Lolait SJ 2003 APJ receptor mRNA expression in the rat hypothalamic paraventricular nucleus: regulation by stress and glucocorticoids. Journal of Neuroendocrinology 15 1095-1101. (Pubitemid 37369171)
36. O'dowd BF, Heiber M, Chan A, Heng HH, Tsui LC, Kennedy JL, Shi X, Petronis A, George SR & Nguyen T 1993 A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136 355-360.
37. Peter JH, Koehler U, Grote L & Podszus T 1995 Manifestations and consequences of obstructive sleep apnoea. European Respiratory Journal 8 1572-1583.
38. Punjabi NM 2008 The epidemiology of adult obstructive sleep apnea. Proceedings of the American Thoracic Society 5 136-143. (Pubitemid 351237871)
39. Reaux-Le GA, vear-Perez R, Zizzari P, Epelbaum J, Bluet-Pajot MT & Llorens-Cortes C 2007 Cellular localization of apelin and its receptor in the anterior pituitary: evidence for a direct stimulatory action of apelin on ACTH release. American Journal of Physiology. Endocrinology and Metabolism 292 E7-E15.
40. Rechtschaffen A & Kales A eds 1968 A Manual of Standardised Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles: Brain Information Service/Brain Research Institute.
41. Reynolds RM, Syddall HE, Walker BR, Wood PJ & Phillips DI 2003 Predicting cardiovascular risk factors from plasma cortisol measured during oral glucose tolerance tests. Metabolism 52 524-527.
42. Ronkainen VP, Ronkainen JJ, Hanninen SL, Leskinen H, Ruas JL, Pereira T, Poellinger L, Vuolteenaho O & Tavi P 2007 Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB Journal 21 1821-1830. (Pubitemid 46855628)
43. Seicean S, Kirchner HL, Gottlieb DJ, Punjabi NM, Resnick H, Sanders M, Budhiraja R, Singer M & Redline S 2008 Sleep-disordered breathing and impaired glucose metabolism in normal-weight and overweight/obese individuals: the Sleep Heart Health Study. Diabetes Care 31 1001-1006.
44. Seyedabadi M, Goodchild AK & Pilowsky PM 2002 Site-specific effects of apelin-13 in the rat medulla oblongata on arterial pressure and respiration. Autonomic Neuroscience 101 32-38. (Pubitemid 36160550)
45. Sheikh AY, Chun HJ, Glassford AJ, Kundu RK, Kutschka I, Ardigo D, Hendry SL, Wagner RA, Chen MM, Ali ZA et al. 2008 In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure. American Journal of Physiology. Heart and Circulatory Physiology 294 H88-H98.
46. Szokodi I, Tavi P, Foldes G, Voutilainen-Myllyla S, Ilves M, Tokola H, Pikkarainen S, Piuhola J, Rysa J, Toth M et al. 2002 Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circulation Research 91 434-440. (Pubitemid 35034212)
47. Tasci I, Dogru T, Naharci I, Erdem G, Yilmaz MI, Sonmez A, Bingol N, Kilic S, Bingol S & Erikci S 2007 Plasma apelin is lower in patients with elevated LDL-cholesterol. Experimental and Clinical Endocrinology and Diabetes 115 428-432. (Pubitemid 47234642)
48. Tasci I, Erdem G, Ozgur G, Tapan S, Dogru T, Genc H, Acikel C, Ozgurtas T & Sonmez A 2009 LDL-cholesterol lowering increases plasma apelin in isolated hypercholesterolemia. Atherosclerosis 204 222-228.
49. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, Kawamata Y, Fukusumi S, Hinuma S, Kitada C et al. 1998 Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochemical and Biophysical Research Communications 251 471-476. (Pubitemid 28505047)
50. Tatemoto K, Takayama K, Zou MX, Kumaki I, Zhang W, Kumano K & Fujimiya M 2001 The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regulatory Peptides 99 87-92. (Pubitemid 32522535)
51. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A & Chrousos GP 2000 Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. Journal of Clinical Endocrinology and Metabolism 85 1151-1158. (Pubitemid 32269364)
52. Wallace TM, Levy JC & Matthews DR 2004 Use and abuse of HOMA modeling. Diabetes Care 27 1487-1495.
53. Wei L, Hou X & Tatemoto K 2005 Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes. Regulatory Peptides 132 27-32. (Pubitemid 41607499)
54. World Health Organisation 2000 Obesity: Preventing and Managing the Global Epidemic. Geneva: World Health Organisation.